FibroBiologics, Inc.
FBLG
$0.35
$0.025.13%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -37.82% | 48.08% | 6.24% | 52.62% | -27.30% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 5.67% | 157.34% | -13.94% | 525.00% | 1,207.41% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | 0.00% | 12.50% | -85.12% |
| Total Current Assets | -36.08% | 56.37% | 4.54% | 54.40% | -24.89% |
|
|
|||||
| Total Current Assets | -36.08% | 56.37% | 4.54% | 54.40% | -24.89% |
| Net Property, Plant & Equipment | 52.18% | 53.18% | -15.26% | -14.93% | -4.78% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -16.48% | 56.05% | 0.24% | 39.12% | -21.28% |
|
|
|||||
| Total Accounts Payable | -9.33% | 49.09% | 74.08% | 86.77% | 43.78% |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | 3,876.52% | 2,710.45% | 1,172.11% | -- | -18.44% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 64.03% | 64.14% | 10.75% | 10.77% | 11.05% |
| Total Finance Division Other Current Liabilities | -91.24% | -94.31% | -95.60% | -93.76% | -- |
| Total Other Current Liabilities | -91.24% | -94.31% | -95.60% | -93.76% | -- |
| Total Current Liabilities | 0.67% | 8.21% | -41.29% | 38.58% | 408.14% |
|
|
|||||
| Total Current Liabilities | 0.67% | 8.21% | -41.29% | 38.58% | 408.14% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 3,876.52% | 2,710.45% | 1,172.11% | -- | -18.44% |
| Capital Leases | 79.81% | 78.49% | -32.26% | -28.95% | -27.09% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 11.47% | 15.47% | -40.53% | 29.73% | 180.04% |
|
|
|||||
| Common Stock & APIC | 45.20% | 55.77% | 47.94% | 49.37% | 39.63% |
| Retained Earnings | -57.07% | -41.43% | -23.36% | -45.82% | -121.44% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -95.43% | 136.03% | 160.83% | 118.28% | -74.03% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -95.43% | 136.03% | 160.83% | 118.28% | -74.03% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -95.43% | 136.03% | 160.83% | 118.28% | -74.03% |
|
|
|||||